The common feature among algorithms currently available is that a low level of serum prostate specific antigen (PSA) (4 ng/ml or lower) associated with a normal digital rectal examination (DRE) indicates the need for neither a transrectal ultrasound (TRUS) examination nor biopsy, and a high level of
State-of-the-art approaches to detecting early bone metastasis in prostate cancer
β Scribed by Ramesh Thurairaja; Jon McFarlane; Zoe Traill; Rajendra Persad
- Book ID
- 109051028
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 76 KB
- Volume
- 94
- Category
- Article
- ISSN
- 1464-4096
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
We used a combination of bone and bone-marrow scintigraphy to study 25 patients with prostatic cancer. Of the 18 cases whose 99mTc-methylene diphosphonate (MDP) bone scans showed hot spots in the lower lumbar region of the spine and/or the pelvic bone, 8 had normal bone-marrow scintigrams. These 8 p
## Abstract Prostate cancer (PCa) epithelial cells require a number of factors to facilitate their establishment and growth at a distant site of metastasis. Their ability to adapt to their microenvironment, proliferate and recruit an underlying stroma is integral to the survival and growth of the m
The American Cancer Society National Prostate Cancer Detection Project (ACS-NPCDP) is a multidisciplinary, multicenter effort to assess the feasibility of early prostate cancer detection by digital rectal examination (DRE), transrectal ultrasound (TRUS), and prostate specific antigen (PSA) assay. By